뒤로
Adagio Medical Holdings Inc(ADGM) 가격
ADGM 주가 차트
ADGM 수입
Adagio Medical Holdings Inc
$0.98
-1.5%
$-0.01
종가: Feb 13, 16:00:00 GMT-5
$0.98
0%
$0
애프터마켓: Feb 13, 20:00:00 GMT-5
Earnings FAQ
ADGM의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Adagio Medical Holdings Inc ADGM의 지난 분기 매출 실적은 어땠나요?
Adagio Medical Holdings Inc의 매출 추정치는 얼마인가요?
Adagio Medical Holdings Inc의 수익 품질 점수는 얼마인가요?
Adagio Medical Holdings Inc는 언제 수익을 보고하나요?
Adagio Medical Holdings Inc의 예상 수익은 얼마인가요?
Adagio Medical Holdings Inc은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$1
시가
$1.09
일일 범위
$0.985 - $1.12
52주 범위
$0.625 - $2.87
거래량
35.3K
평균 거래량
165.5K
EPS(TTM)
-4.75
배당수익률
--
시가총액
$20.8M
ADGM란 무엇인가요?
Adagio Medical Holdings, Inc. is a medical device company, which engages in the development ablation technologies for the treatment of cardiac arrhythmias. The company is headquartered in Laguna Hills, California and currently employs 86 full-time employees. The company went IPO on 2021-02-26. The company is focused on developing proprietary Ultra-Low Temperature Cryoablation technology that creates contiguous, transmural lesions to treat cardiac arrhythmias, with an emphasis on ventricular tachycardia. The company is developing and placing on the European Union (EU) market ablation technologies for the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. Its product portfolio consists of three product families: iCLAS atrial ULTC catheter and accessories, vCLAS ventricular ULTC catheter, and Cryopulse atrial PFCA catheter and accessories. All of these catheters share the same ULTC cryoablation console. The iCLAS system is CE-marked with the indication for treatment of paroxysmal atrial fibrillation, persistent atrial fibrillation and atrial flutter. The vCLAS ventricular catheter has been specifically designed for the treatment of ventricular arrhythmia.